snc-logo

Start-Up Nation Finder

Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
My Smartlists
My Saved Searches
Inbox
About Us
Glossary

Add companies to smartlist

45 companies were selected
Add smartlist note (optional)

Create new smartlist

Smartlist name*
Smartlist must have a valid name.
Description (optional)
Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

The invitation to claim the profile was originally sent to

or  

Hey #USER_FULLNAME#!
Claim #COMPANY_NAME# ’s profile to become an administrator with editing privileges in
#COMPANY_NAME# ’s page on Start-Up Nation Finder

Suggest Edits

Let us know what you think is inaccurate or missing.
We will check it out and update the profile if needed.

Claim Profile

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Already have an account? Login

Nice work!

To continue the registration process,
please check your email inbox at email@email.com
to validate your account.

We'll see you back here soon. :-)

Do not forget to check your spam folder

Didn’t get the email? Resend email or Contact us

Reset password
Don't have an account? Sign up

Check your mailbox

We sent you an email with further instructions to
email@email.com

Do not forget to check your spam folder

Didn’t get the email? Resend email or Contact us

Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

Save Search

Search must have a valid name.
Search Was Saved

Rename Search

Search must have a valid name.
Search Was Saved
Delete Saved Search Confirmation
search will be permanently removed from Finder.
Home > Companies > BTG
Claimed by owner Last Update 21.7.2021 Suggest Edits Claim Profile
Claimed by owner
BTG logo

BTG

Genetically Engineered Drugs

Non Visible
Acquired by Ferring Pharmaceuticals on Jan, 2005
BTG
About
Lifecycle
News
Gallery

About

Bio-Technology General Israel (BTG) is an integrated biopharmaceutical services company that develops and manufactures healthcare products derived from genetic engineering and biotechnology processes.

BTGs Biolon, first introduced in 1993, is an injectable system containing 1% fermentation-derived sodium hyaluronate (NaHA) used as a viscoelastic aid in cataract and other ophthalmic surgeries.

Euflexxa is a treatment to help relieve knee pain due to osteoarthritis (OA). It is used by thousands of people to help manage OA knee pain and stay active. Containing 1% fermentation-derived sodium hyaluronate, Euflexxa is intended for intra-articular injection into the knee.

Developed in the 1980s, BTGs recombinant human growth hormone (somatropin for injection or hGH) first gained regulatory approval in 1988. It is identical to natural human growth hormone synthesized by the pituitary gland, and is used to treat Turner syndrome and growth hormone deficiency in children.

BTG is a wholly owned subsidiary of Ferring Pharmaceuticals.

Founded

Business models

Employees

Product stage

Primary Sector

Life Sciences & HealthTech

Products

Somatropin, EUFLEXXA, Biolon

Geographic markets

Asia, Canada, Japan, United States, Australia, Europe, South America

Funding

Total Funding

$26.93M

Last Funding

$15M

Funding Stage

Total Rounds

4

Investors

1

The Team

(4)
RA
Ron Asafrana
Head of Finance
Connect
NA
Noa Avigdor
Head of Manufacturing
Connect
DP
Dror Peretz
Operational Excellence
Connect
EHS
Efrat Horowitz Sivan
Senior Manager Human Resources
Connect

Connect with

What is the reason for connecting?
Your company *
Your position *
Add invitation message
0/300

Sending invitation...

Company Lifecycle

Event View
Timeline View

Public Offerings & Exits

M&A EXIT
Undisclosed
Jan 2005
Type Acquisition
Undisclosed

Private Equity Funding

Post-IPO Equity Funding
$4.01M
Jan 2015
0 Investors
$4.01M
Post-IPO Equity Funding
$3.85M
Jun 2015
0 Investors
$3.85M
Post-IPO Equity Funding
$4.07M
Feb 2016
0 Investors
$4.07M
Post-IPO Equity Funding
$15M
May 2018
1 Investors
$15M

Locations

Israel

Be'er Tuvia, Israel

Offices Abroad

Sector

Life Sciences & HealthTech
Pharma & Biomedicine
Discovery & Development

Core Technology

Biologicals

Target Customer

Healthcare & Life Sciences
Life Sciences
Biotechnology
Pharmaceuticals
Healthcare
Patients

Tags

(10)

Locations

Israel

Be'er Tuvia, Israel

Offices Abroad

Notes

Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Unlock financial data
Finder is provided for free by the non-profit organization Start-Up Nation Central.
  • Get unlimited search results
  • Save to custom lists - Smartlists
  • Get notified with news and updates
  • Connect with people
And much more...
I already have access,
I already have access,